Allograft arteriosclerosis is an important characteristic of chronic graft
rejection. In allograft arteriosclerosis there is a striking loss of medial
smooth muscle cells (SMCs) before the development of a concentric intimal
proliferative response. In this study we evaluated the role of CD8+ T lymph
ocytes in this medial SMC loss. Brown Norway aortic segments were transplan
ted into Lewis animals for 60 days (long alloexposure) or 20 days (short al
lo-exposure). After 20 days allogeneic exposure aortic segments were transp
lanted back into syngeneic (Brown Norway) animals for 40 days. Experimental
animals were treated with mAb to CD8, Apoptosis was measured by terminal d
UTP nick-end labeling at 20 days and morphometry analyzed at 60 days to eva
luate medial and intimal changes. Anti-CD8 treatment significantly lowered
CD8+ T cell counts in peripheral blood, reduced medial SMC apoptosis at 20
days, and increased medial SMC counts at 60 days. Both short- and long-allo
geneic exposure groups confirmed these findings and demonstrated that media
l SMC loss is proportional to the length of allogeneic exposure. Antibody d
epletion of CD8+ T cells results in reduced medial SMC apoptosis and better
medial SMC preservation. This supports the hypothesis that medial SMC loss
occurs by apoptotic death and is driven by CD8+ T lymphocytes.